Action of a serotonergic anorectic in meal-fed mice working for food

Neil E Rowland1, Kimberly L Robertson, Emilia M Cadiz

  • 1Department of Psychology, University of Florida, Gainesville, Florida 32611-2250, USA. nrowland@ufl.edu

Insights

Dexnorfenfluramine (DNOR), a weight-loss drug, reduced food intake in mice. This appetite suppressant effect was stronger when obtaining food required more effort, demonstrating its interaction with food accessibility.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Appetite regulation is complex, influenced by both neurochemical signals and environmental factors.
  • Serotonergic agents, like dexnorfenfluramine (DNOR), are known for their effects on satiety and food intake.
  • Understanding how drug efficacy is modulated by external variables is crucial for therapeutic applications.

Purpose of the Study:

  • To investigate the anorectic effects of dexnorfenfluramine (DNOR) in mice.
  • To determine if the cost of food (effort required to obtain it) influences DNOR's impact on food consumption.
  • To analyze the temporal dynamics of DNOR's effect within a feeding period.

Main Methods:

  • Mice were trained to obtain food pellets by performing a fixed unit price (FUP) of nose pokes (FUP2 or FUP25).
  • Food availability was restricted to four 40-minute periods daily, mimicking human meal patterns.
  • Mice received injections of DNOR (3 or 6 mg/kg) or vehicle before feeding opportunities.

Main Results:

  • DNOR significantly suppressed food intake in a dose-dependent manner.
  • The anorectic effect of DNOR was amplified when the effort required to obtain food was higher (FUP25).
  • DNOR's impact was most pronounced during the initial phase of the feeding period.

Conclusions:

  • The anorectic efficacy of dexnorfenfluramine is modulated by the cost of food, indicating an interaction between pharmacological and environmental factors.
  • DNOR's effectiveness in reducing food intake is context-dependent.
  • These findings contribute to understanding the behavioral pharmacology of appetite suppressants.

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...